🕵️ Haemonetics Corp ($HAE)
SEC insider & ownership activity, last 12 months · CIK 313143 · every row links its SEC filing
Over the last 12 months insiders bought $99K with no open-market selling against it. Mark W. Kroll bought $99K in discretionary trades (Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $99K (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Mark W. Kroll | 1 | $99K | 0 | – | Nov 10, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| AQR Capital Management, LLC | 6.8% | 13G | Feb 13, 2026 | filing ↗ | |
| AQR Capital Management Holdings, LLC | 6.8% | 13G | Feb 13, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 5.6% | 13G | Apr 29, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.3% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 24, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 12, 2026 | filing ↗ |
| Earnings (2.02) | Feb 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing ↗ |
| Other events (8.01) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |